Search

everythinglearnresearchcommunity

for

Search:↓

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

PRP injections can effectively treat alopecia areata.

Better models and evaluation methods for alopecia areata are needed.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib may help treat severe hair loss, but more research is needed.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Minoxidil helps hair growth in 63.6% of alopecia patients, with 27.3% having excellent results.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

PRP more effective than minoxidil 5% for treating alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.